IP Library Granted Patent US 8,809,805
Granted Patent B2
US 8,809,805 · App. 13/855,971 · Granted Aug 19, 2014

Radiation shield lid for self-aligning radioisotope elution system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,809,805
App. No.
13/855,971
Granted
Aug 19, 2014
Kind
B2
Abstract

A radiation shield lid for shielding a radioisotope generator. The radiation shield lid includes an alignment structure configured to align the shield lid to a radioisotope generator.

Claims (16)

1. A radiation shield lid comprising:

a top and an opposing bottom, wherein the bottom comprises a bottom surface;

a first aperture defined in the lid and extending completely through the lid from the top to the bottom;

a second aperture defined in the lid and extending completely through the lid from the top to the bottom, wherein the second aperture is separate from the first aperture; and

a male alignment structure extending downward from the bottom surface away from the top of the lid, the male alignment structure having a periphery that surrounds the first and second apertures at the bottom surface of the lid;

wherein the lid comprises at least one radiation shielding material selected from depleted uranium, tungsten, tungsten impregnated plastic, or lead.

2. The radiation shield lid of claim 1 , wherein sidewalls of the shield lid are substantially parallel to sidewalls of the male alignment structure.

3. The radiation shield lid of claim 1 in combination with an auxiliary shield that has a first complementary alignment structure that is keyed to the male alignment structure on the lid and a second complementary alignment structure that is keyed to another alignment structure on a radioisotope generator.

4. The radiation shield lid of claim 1 , wherein the male alignment structure is integrally formed with the bottom surface of the shield lid.

5. The radiation shield lid of claim 1 in combination with an auxiliary shield having a generator receptacle defined therein, wherein at least the male alignment structure on the shield lid fits within the generator receptacle.

6. The radiation shield lid of claim 1 , wherein the male alignment structure defines a right cylinder with an oval base.

7. The radiation shield lid of claim 1 , wherein the male alignment structure further comprises a substantially planar surface that extends from the periphery to the first and second apertures.

8. The radiation shield lid of claim 1 , further comprising a pair of handles extending from the top of the shield lid.

9. The radiation shield lid of claim 8 , wherein each of the pair of handles is U-shaped.

10. The radiation shield lid of claim 1 , wherein the first and second apertures each have a constant circular cross-section through at least a portion of the shield lid.

11. The radiation shield lid of claim 1 , wherein the first aperture includes a flared portion at the top of the shield lid.

Assignments (3)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
CHANGE OF NAME Recorded Apr 3, 2023
From: MALLINCKRODT NUCLEAR MEDICINE LLC
To: CURIUM US LLC
Reel/Frame 063240/0591 →
RELEASE OF SECURITY INTEREST Recorded Jan 31, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: MALLINCKRODT NUCLEAR MEDICINE LLC
Reel/Frame 041131/0213 →